Literature DB >> 24892309

Incorporating patients with chronic heart failure into outpatient cardiac rehabilitation: practical recommendations for exercise and self-care counseling-a clinical review.

Steven J Keteyian1, Ray W Squires, Philip A Ades, Randal J Thomas.   

Abstract

PURPOSE: A recent policy change from the Centers for Medicare and Medicaid Services includes coverage of cardiac rehabilitation (CR) for patients with chronic heart failure (CHF) with reduced ejection fraction. This article provides a framework by which CR programs can incorporate disease-specific services for patients with CHF who participate in CR. DISCUSSION: Cardiac rehabilitation should include self-care counseling that targets improved education and skill development (eg, medication compliance, monitoring/management of body weight). Various tools are available for assessing exercise tolerance (eg, stress test with gas exchange and 6-minute walk), health-related quality of life, and other outcome-related parameters. Exercise should be prescribed in a manner that progressively increases intensity, duration, and frequency, to a volume of exercise equivalent to 3 to 7 metabolic equivalent task (MET)-hr per week. The benefits of exercise training are limited by patient adherence; therefore, CR providers need to identify the adherence challenges unique to each patient and address each accordingly. To optimize the referral of patients with CHF to CR, program staff should develop strategies to raise both health care provider and patient awareness about the benefits of CR, as well as work collaboratively to set up system-based approaches to CR referral.
CONCLUSIONS: The referral of patients with CHF to CR will increase in 2014 and beyond, due partly to a policy change from the Centers for Medicare and Medicaid Services that allows coverage for CR. These patients should be integrated into existing programs, with the intent of providing both standard CR services and CHF-specific education and disease management activities that target improved outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24892309     DOI: 10.1097/HCR.0000000000000073

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  6 in total

Review 1.  Cardiac Rehabilitation in Patients with Established Atherosclerotic Vascular Disease: New Directions in the Era of Value-Based Healthcare.

Authors:  Karen Aspry; Wen-Chih Wu; Elena Salmoirago-Blotcher
Journal:  Curr Atheroscler Rep       Date:  2016-02       Impact factor: 5.113

Review 2.  Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity.

Authors:  Jenna L Taylor; Amanda R Bonikowske; Thomas P Olson
Journal:  Front Cardiovasc Med       Date:  2021-09-03

3.  "I Just Can't Do It Anymore" Patterns of Physical Activity and Cardiac Rehabilitation in African Americans with Heart Failure: A Mixed Method Study.

Authors:  Margaret McCarthy; Stuart D Katz; Judith Schipper; Victoria Vaughan Dickson
Journal:  Healthcare (Basel)       Date:  2015-10-15

4.  A multidisciplinary telehealth program in patients with combined chronic obstructive pulmonary disease and chronic heart failure: study protocol for a randomized controlled trial.

Authors:  Palmira Bernocchi; Simonetta Scalvini; Tiziana Galli; Mara Paneroni; Doriana Baratti; Ottavia Turla; Maria Teresa La Rovere; Maurizio Volterrani; Michele Vitacca
Journal:  Trials       Date:  2016-09-22       Impact factor: 2.279

5.  Low ALT blood levels are associated with lower baseline fitness amongst participants of a cardiac rehabilitation program.

Authors:  Michael Kogan; Robert Klempfner; Dor Lotan; Yishay Wasserstrum; Ilan Goldenberg; Gad Segal
Journal:  J Exerc Sci Fit       Date:  2017-11-29       Impact factor: 3.103

6.  Predicting maximal oxygen uptake from the 6 min walk test in patients with heart failure.

Authors:  Pallav Deka; Bunny J Pozehl; Dola Pathak; Mark Williams; Joseph F Norman; Windy W Alonso; Tiny Jaarsma
Journal:  ESC Heart Fail       Date:  2020-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.